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CD34 in Human Hair Follicle
To the Editor:
CD34, also known as human hematopoietic progenitor cell anti-
gen, is a heavily glycosylated transmembrane protein expressed
on developmentally early lymphohematopoietic stem and pro-
genitor cells, and on a signi¢cant number of acute leukemias
(Krause et al, 1996). In human skin CD34 has been described in
vascular endothelial cells, in a subset of dendritic/spindle-shaped
cells (Nickolo¡, 1991), and in some cutaneous tumors (Cohen et al,
1997).
In a previously published study we could demonstrate the ex-
pression of CD34 in cells from the outer root sheath of hair fol-
licles (Poblet et al, 1994). In that study, sections from normal
human skin of formalin-¢xed, para⁄n-embedded biopsies were
immunostained with a monoclonal antiCD34 antibody (clone
QBEND/10). A clear membranous staining of outer root sheath
cells could be observed. This was the ¢rst report to demonstrate
the CD34 expression in a certain type of keratinocytes. We
showed that the CD34 staining was very speci¢c for epithelial
cells of the external root sheath, and that the staining was limited
to cells located below the attachment of the arrector pili muscle
and above the matrix cells. Because CD34 is a progenitor cell
antigen we suggested a possible relation of these cells with stem
cells of hair follicles.
We read with interest the excellent article byTrempus et al that
has recently appeared in this Journal (Trempus et al, 2003). These
authors demonstrate CD34 immunohistochemical staining of
murine hair follicle bulge keratinocytes. In addition they con-
¢rmed the presence of CD34 mRNA in that cells. In general,
the immunohistochemical staining pattern of murine keratinocytes
concords with the staining pattern that we described in
human hair follicle keratinocytes, although the bulge region in
human hair follicles can not be as readily identi¢ed as it is in mice
hair follicles.
Enrique Poblet MD and Francisco JimeŁ nez MDwDepartment of Pathology, Hospital General Universitario de
Albacete, Spain; wDermatology and Laser Center Cl|¤ nica San Roque,
Las Palmas Gran Canaria, Canary Islands, Spain.
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Response
To the Editor:
We are writing in response to the Letter to the Editor
submitted by Poblet and Jiminez entitled ‘‘CD34 in the Human
Hair Follicle.’’ In this letter, they point out that we neglected
to refer to their 1994 paper ‘‘QBEND/10 (Anti-CD34 Antibody)
in External Root Sheath Cells and Follicular Tumors’’ (Poblet
LETTERS TO THE EDITOR
Manuscript received April 23, 2003; accepted for publication May 16,
2003
1220 INDELMAN ETAL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
et al, 1994) in our manuscript (Trempus et al, 2003) published
in a recent issue of JID.We inadvertently omitted that article in
our paper and we certainly acknowledge that their ¢ndings
clearly demonstrated CD34 expression in human follicular
keratinocytes and cutaneous tumors. We do not believe that
this omission alters the novelty or accuracy of our data and
conclusions.
Carol S. Trempus, MS, Rebecca J. Morris, PhDw,
George Cotsarelis, MD
RaymondW. Tennant, PhD
National Center for Toxicogenomics, National Institute of
Environmental Health Sciences, Research Triangle Park, NC;
University of Pennsylvania Medical School, Philadelphia, PA and
wColumbia University, College of Physicians and Surgeons,
Department of Dermatology, NewYork, NY
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A Novel GJB2 (Connexin 26) Mutation, F142L, in a Patient with
Unusual Mucocutaneous Findings and Deafness
To the Editor:
Mutations in GJB2, encoding the gap junction b-2 protein con-
nexin (Cx) 26, cause hearing loss with or without skin disorders.
Mutations in other connexin genes cause hearing loss, skin disor-
ders, peripheral neuropathies, and craniofacial and limb dys-
morphisms (Table I; Kelsell et al, 2001; Rabionet et al, 2002;
Paznekas et al, 2003).
A 2 y old Caucasian female with psoriasiform mucocutaneous
involvement, in£ammation of mucous membranes, and severe to
profound, bilateral, sensorineural hearing loss was ascertained.
Hearing loss was diagnosed by auditory brainstem response test
(ABR) at 13 mo of age after failure to develop speech. Cutaneous
¢ndings include: (1) periori¢cial and truncal erythematous
patches and scaly erythematous plaques that also involve the face,
upper extremities, and diaper area (Fig 1A); (2) exuberant granu-
lation tissue around a gastrostomy and on the perianal skin; (3)
scaling and obstruction of the external auditory canals; (4) scaly
crusted plaques on the scalp; (5) sparse hair that has ¢lled in with
age; and, (6) calcinosis cutis of both heels. There is no palmoplan-
tar hyperkeratosis, nail or hair dysplasia. Skin biopsy reveals
mostly orthokeratotic hyperkeratosis with focal parakeratosis,
acanthosis, and slight papillomatosis of the epidermis, and foci
of acute and chronic in£ammation in the subepidermal layer
and epidermis.
Oral ¢ndings include multiple large dental lamina cysts (Fig 1B)
that resolved spontaneously, and primary teeth with focal enamel
hypoplasia. The oropharyngeal mucosa shows di¡use erythema
with focal ulceration, corrugation, and adherent white plaques
(Fig 1C). Intermittent angular cheilitis is observed. Histopatholo-
gic features of the oral mucosa show hyperparakeratosis, acan-
thosis, and scattered neutrophils in the super¢cial epithelium
adjacent to an ulcer.
Endoscopy of the upper gastrointestinal tract reveals a denuded
and friable esophagus with marked mucosal in£ammation incon-
sistent with Crohn’s disease, and esophageal stricture. The muco-
sal involvement impairs swallowing, resulting in the placement
of a gastrostomy.
Other problems include recurrent urinary tract infections,
perirectal abscesses, otitis externa, otitis media, iron de¢ciency
anemia, and reactive thrombocytosis. At 17 mo of age, a brain
magnetic resonance imaging showed a mild delay in myelination.
Table I. Connexins in deafness, skin disease,
and other disorders
Protein Gene symbol Phenotypes
Cx26 GJB2 Nonsyndromic hearing loss
Keratitis-ichthyosis-deafness syndrome
Hystrix-like ichthyosis-deafness syndrome
Vohwinkel syndrome (mutilating keratoderma
and hearing impairment)
Di¡use palmoplantar keratoderma and deafness
Cx30 GJB6 Nonsyndromic hearing loss
Clouston syndrome (hidrotic ectodermal dysplasia)
Cx30.3 GJB4 Erythrokeratodermia variabilis
Cx31 GJB3 Nonsyndromic hearing loss
Erythrokeratodermia variabilis
Peripheral neuropathy and hearing loss
Cx32 GJB1 Charcot-Marie-Tooth disease with or without
hearing loss
Cx43 GJA1 Nonsyndromic hearing loss
Oculodentodigital dysplasia
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